TechDogs-"Live Cell Imaging Global Market Expected to Reach $3.73 Billion in 2022 - ResearchAndMarkets.com"

Market Research

Live Cell Imaging Global Market Expected to Reach $3.73 Billion in 2022 - ResearchAndMarkets.com

By Business Wire

Business Wire
Overall Rating


DUBLIN--(BUSINESS WIRE)--The "Live Cell Imaging Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

The global live cell imaging market is expected to grow from $3.41 billion in 2021 to $3.73 billion in 2022 at a compound annual growth rate (CAGR) of 9.2%. The market is expected to grow to $5.50 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%.

The live-cell imaging market consists of sales of live cell imaging by entities (organizations, sole traders, and partnerships) that are engaged in manufacturing and selling live cell imaging equipment and consumables. Live-cell imaging equipment helps in providing a detailed study of internal structures and cellular processes for understanding the cellular structures of cell biology. It also gives information on cells, proteins, and molecular interactions.

The main types of live cell imaging products include equipment, consumables, software. Equipment is the set of articles or physical resources serving to equip a person or thing. The technology used in live-cell imaging is time-lapse microscopy, fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high content screening (HCS), others. Live-cell imaging finds its applications in cell biology, developmental biology, stem cell, and drug discovery, among others. It is used in various sectors including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs).

The rising incidence of cancer is expected to drive the growth of the live cell imaging market in the forecast period. Cancer is the second major cause of death worldwide, accounting for one out of every six deaths each year. For example, cancer cases are projected to increase to 29.5 million and cancer-related deaths to 16.4 million worldwide by 2040. In the United States, there were 16.9 million cancer patients in 2019, with the number expected to rise to 22.2 million by 2030. Live-cell imaging technology plays a crucial role in the advancement and validation of cancer immunotherapy through visualization, characterization, and evaluation of the biological process of living cells. Therefore, the rising incidence of cancer fuels the growth of the live cell imaging market.

Key Topics Covered:

1. Executive Summary

2. Live Cell Imaging Market Characteristics

3. Live Cell Imaging Market Trends And Strategies

4. Impact Of COVID-19 On Live Cell Imaging

5. Live Cell Imaging Market Size And Growth

5.1. Global Live Cell Imaging Historic Market, 2016-2021, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global Live Cell Imaging Forecast Market, 2021-2026F, 2031F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market

6. Live Cell Imaging Market Segmentation

6.1. Global Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

6.2. Global Live Cell Imaging Market, Segmentation By Technology , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

6.3. Global Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

6.4. Global Live Cell Imaging Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7. Live Cell Imaging Market Regional And Country Analysis

8. Asia-Pacific Live Cell Imaging Market

9. China Live Cell Imaging Market

10. India Live Cell Imaging Market

11. Japan Live Cell Imaging Market

12. Australia Live Cell Imaging Market

13. Indonesia Live Cell Imaging Market

14. South Korea Live Cell Imaging Market

15. Western Europe Live Cell Imaging Market

16. UK Live Cell Imaging Market

17. Germany Live Cell Imaging Market

18. France Live Cell Imaging Market

19. Eastern Europe Live Cell Imaging Market

20. Russia Live Cell Imaging Market

21. North America Live Cell Imaging Market

22. USA Live Cell Imaging Market

23. South America Live Cell Imaging Market

24. Brazil Live Cell Imaging Market

25. Middle East Live Cell Imaging Market

26. Africa Live Cell Imaging Market

27. Key Mergers And Acquisitions In The Live Cell Imaging Market

28. Live Cell Imaging Market Future Outlook and Potential Analysis

Companies Mentioned

  • Leica Microsystems
  • Olympus Corporation
  • Sigma-Aldrich Corporation
  • PerkinElmer inc.
  • GE Healthcare
  • Carl Zeiss Meditec AG
  • Becton Dickinson and Company
  • Molecular Devices LLC
  • Bruker Corporation
  • Sartorius AG
  • Oxford Instruments
  • BioTek Instruments
  • Etaluma inc.
  • CytoSMART Technologies

For more information about this report visit https://www.researchandmarkets.com/r/h0oihe

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Liked what you read? Head to the TechDogs homepage to find the latest tech content infused with drama and entertainment. We've got ArticlesWhite PapersCase StudiesReportsVideos and Events that help you Know Your World of Technology.

First published on Tue, Jul 5, 2022

Enjoyed what you read? Great news – there’s a lot more to explore!

Dive into our content repository of the latest tech news, a diverse range of articles spanning introductory guides, product reviews, trends and more, along with engaging interviews, up-to-date AI blogs and hilarious tech memes!

Also explore our collection of branded insights via informative white papers, enlightening case studies, in-depth reports, educational videos and exciting events and webinars from leading global brands.

Head to the TechDogs homepage to Know Your World of technology today!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs’ members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs’ Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. All information / content found on TechDogs’ site may not necessarily be reviewed by individuals with the expertise to validate its completeness, accuracy and reliability.

Tags:

ResearchAndMarkets CytoSMART Technologies Biotechnology

Join The Discussion

- Promoted By TechDogs -

Copilot For Microsoft 365 Adoption Playbook